Long-term follow up of children with congenital complete atrioventricular block and the impact of pacemaker therapy
Why the study?
Does pacemaker therapy improve survival and reduce morbidity in children with congenital complete atrioventricular block?
Population
32 children with Congenital Complete Atrioventricular Block, diagnosed at a median age of 0.4 years. 23…
Comparison
Pacemaker (PM) therapy vs Natural history data (no pacemaker)
Design
Cohort
Follow-up
median 10.2 years
Authors
Discussion
Loading...
Member takes
Implication
Frequent complications warrant close monitoring in paced children with CCAVB; leaves open optimal strategies for this population.
Structured PICO
Does pacemaker therapy improve survival and reduce morbidity in children with congenital complete atrioventricular block?
P
Population
32 children with Congenital Complete Atrioventricular Block (CCAVB), diagnosed at a median age of 0.4 years (range foetal-10 years). 23 without structural heart disease, 9 with structural heart disease.
I
Intervention
Pacemaker (PM) therapy
C
Comparator
Natural history data (no pacemaker)
O
Outcome
Survival and morbidityhard clinical
Pacemaker therapy in children with congenital complete atrioventricular block eliminates CCAVB-related symptoms and reduces mortality, though pacemaker-related complications remain common.
Cite This Study
Christian Balmer (2002) studied this question.